Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1994
Phase Ib trial of granulocyte-macrophage colony-stimulating factor combined with murine monoclonal antibody R24 in patients with metastatic melanomaA Chachoua, R Oratz, L Liebes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 1995
High-dose chemotherapy combined with escalating doses of cyclosporin A and an autologous bone marrow transplant for the treatment of drug-resistant solid tumors: a phase I clinical trialP J Stiff, R Bayer, S Tan, et al.
Journal of Neurosurgery|March 1, 1996
Sinus skeletonization: a treatment for dural arteriovenous malformations of the tentorial apex. Report of two casesC P Lucas, E De Oliveira, H Tedeschi, et al.
Clinical Neuropharmacology|April 1, 1992
Effect of a low-tryptophan diet as an adjuvant to conventional neuroleptic therapy in schizophreniaR B Rosse, B L Schwartz, S Zlotolow, et al.
Bone Marrow Transplantation|May 16, 2006
Prolonged responses after autologous stem cell transplantation in African-American patients with multiple myelomaS Saraf, Y-H Chen, L C Dobogai, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 16, 2010
25-OH-vitamin D deficiency and cellular alloimmunity as measured by panel of reactive T cell testing in dialysis patientsD Sawinski, J Uribarri, D Peace, et al.
Cancer Research|May 8, 1999
Phase I evaluation of humanized OKT3: toxicity and immunomodulatory effects of hOKT3gamma4J Richards, J Auger, D Peace, et al.
Bone Marrow Transplantation|September 12, 2000
Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell diseaseK van Besien, A Bartholomew, W Stock, et al.
Journal of the National Cancer Institute|May 6, 1992
Modulation of monocyte functions by muramyl tripeptide phosphatidylethanolamine in a phase II study in patients with metastatic melanomaL Liebes, C M Walsh, A Chachoua, et al.
Pageof 4